72-Year-Old Woman With Double Vision, Dysarthria, and Ptosis

Samuel Kosydar,Christopher R. Stephenson
DOI: https://doi.org/10.1016/j.mayocp.2023.08.030
IF: 11.104
2024-06-03
Mayo Clinic Proceedings
Abstract:Guillain-Barré syndrome is an autoimmune disorder affecting peripheral nerves with an estimated incidence rate of approximately 1 to 2 cases per 100,000 person-years. 6 The disease is characterized by progressively worsening symmetric weakness that is typically associated with a preceding infection. Postinfectious COVID-19–associated GBS is well documented, and our patient had COVID-19 diagnosed 1 week before the current presentation. 10 Diagnostic criteria for GBS per the National Institute of
medicine, general & internal
What problem does this paper attempt to address?